Signature Equity Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Signature Equity Partners's DGX Position: Q2 2026 in Review
Signature Equity Partners increased its Quest Diagnostics (DGX) stake by 2.4% in Q2 2026, buying an estimated $196 and bringing the position to 43 shares worth $9.16K. The position accounts for ﹤0.01% of the portfolio, ranked #835.
Signature Equity Partners first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Signature Equity Partners held 43 shares of Quest Diagnostics worth $9.16K as of Q2 2026.
- Signature Equity Partners bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
- Quest Diagnostics made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #835 holding.
- Signature Equity Partners first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.